Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients

NCT00520260 is registered in ClinicalTrials.gov with Florida Eye Microsurgical Institute as lead sponsor.

NCT NCT00520260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00520260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients
Lead sponsor
Florida Eye Microsurgical Institute
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2007
Completion date
August 31, 2008
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, ocular comfort